• Vertex Pharmaceuticals average return on equity for 2023 was 23.45, a 14.7% decline from 2022.
• Vertex Pharmaceuticals average return on equity for 2022 was 27.49, a 5.12% decline from 2021.
• Vertex Pharmaceuticals average return on equity for 2021 was 26.15, a 21.16% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.